Hjem › Precursor T-celle lymfoblastisk leukemi-lymfom › Texas
Kliniske studier for Precursor T-celle lymfoblastisk leukemi-lymfom i Texas
8 studier for Precursor T-celle lymfoblastisk leukemi-lymfom søker deltakere på steder i Texas.
Byer i Texas
Offisiell studietekst (engelsk)
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- MD Anderson Cancer Center, Houston
- Sarah Cannon Transplant and Cellular Therapy Methodist Hospital, San Antonio
RekruttererFase 2
6 Months · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06514794A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy)
- MD Anderson Cancer Center, Houston
RekruttererFase 2
1 Month – 21 Years · Alle kjønn · Oppdatert 18. sep. 2026 · NCT06561074Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma
- MD Anderson Cancer Center, Houston
RekruttererFase 1
Opp til 39 år · Alle kjønn · Oppdatert 11. sep. 2026 · NCT04972942Venetoclax, Dexamethasone, Bortezomib, and Daratumumab For The Treatment Of Adolescent And Young Adults With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And T-cell Acute Lymphoblastic Lymphoma
- UT MD Anderson, Houston
RekruttererFase 1
Alder 12 til 30 · Alle kjønn · Oppdatert 12. aug. 2026 · NCT07513129Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen
- Houston Methodist Hospital, Houston
- Texas Children's Hospital, Houston
RekruttererFase 1
Opp til 75 år · Alle kjønn · Oppdatert 11. aug. 2026 · NCT03081910Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- M D Anderson Cancer Center, Houston
RekruttererFase 2
Alle aldre · Alle kjønn · Oppdatert 15. jul. 2026 · NCT00501826A Registry for People With T-cell Lymphoma
- MD Anderson Cancer Center (Data Collection Only), Houston
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 20. mai 2026 · NCT05978141Novel Unedited Allo Cell Therapy For High Risk T-Cell Malignancies Using CD7-Specific Car T Cells
- Houston Methodist Hospital, Houston
- Texas Children's Hospital, Houston
RekruttererFase 1
Opp til 75 år · Alle kjønn · Oppdatert 18. mai 2026 · NCT07220993Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.